Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Form Health vs PeptidesRx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.7

Form Health

Best for comprehensive concierge care

Starting at $1350/mo

Brand NameSemaglutideTirzepatide
Visit Form Health
7.9

PeptidesRx

Best for patients prioritizing regulatory compliance in the compounded space

Starting at $169/mo

CompoundedSemaglutideTirzepatidePhysician supervised
Visit PeptidesRx

Side-by-Side Comparison

FeatureForm HealthPeptidesRx
Overall Score6.7/107.9/10
Starting Price$1350/mo$169/mo
Customer Rating
Features3 features6 features
States Available5050
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Form Health

Pros

  • Both semaglutide and tirzepatide available
  • Brand-name FDA-approved medications

Cons

  • Higher brand-name pricing only
  • Premium pricing relative to market

PeptidesRx

Pros

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Cons

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

Our Verdict

Winner: PeptidesRxScore: 7.9/10

PeptidesRx edges out Form Health with a higher overall score of 7.9/10 and is particularly strong for patients prioritizing regulatory compliance in the compounded space. Form Health remains a solid alternative, especially if you're looking for comprehensive concierge care.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.